The prognosis value of the ratio of miR-142 between serum and CD4+ T cells in heart failure

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900025236

Enrollment

Unknown

Registered

2019-08-17

Start date

2019-09-01

Completion date

Unknown

Last updated

2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

heart failure

Interventions

NYHA I-II group + NYHA III-IV group + control group:N/A

Eligibility

Sex/Gender

All

Age

45 Years to 80 Years

Inclusion criteria

Inclusion criteria: According to 2016 heart failure diagnosis criteria.

Exclusion criteria

Exclusion criteria: Exclusion criteria: psychiatric disorders and incomplete investigators; cirrhosis of the liver, renal failure or various malignant tumors; patients with severe asthma, bronchiectasis, chronic obstructive pulmonary disease and idiopathic pulmonary interstitial fibrosis; former drug users, or infected with infectious diseases such as AIDS, syphilis.

Design outcomes

Primary

Measure	Time frame
mir-142;BNP;Echocardiography;6 min walking test;readmission;	—

Countries

China

Contacts

Public ContactLidong Cai

Department of Cardiology, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine

lidongcai1986@outlook.com+86 18721383320

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026